Magdalena Krajewska

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

Pervinder Sagoo, Esperanza Perucha, Birgit Sawitzki et al. · Journal of Clinical Investigation · 2010 · 515 citations · Full text

Cross-platform Biomarker Signature, Immune Tolerance, Transplant Recipients +27

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study

Michel Jadoul, J.-L. Poignet, Colin Geddes et al. · Nephrology Dialysis Transplantation · 2004 · 187 citations · Full text

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni et al. · Nature Genetics · 2023 · 156 citations · Full text

Genome-wide Association Study, Glomerulonephritis, Genome-wide Association +15